tirzepatide
-
Psychiatric Symptoms Reported in Some Patients After Stopping GLP-1 Medications
Medical reports identify rare cases of hallucinations and mania in patients who discontinued GLP-1 receptor agonist drugs like tirzepatide.
-
Weight Loss Medication in 2025: Safety, Shortages, and the Surge of Counterfeits
As breakthrough weight loss drugs reshape obesity treatment, 2025 brings new hope—and new risks. From FDA-approved injections to counterfeit dangers and WHO warnings about limited access, this deep dive reveals the realities behind the headlines.